Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENTS OF FINANCIAL POSITION

v3.22.2
CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - USD ($)
Mar. 31, 2022
Mar. 31, 2021
Current assets:    
Cash and cash equivalents $ 21,756 $ 17,621
Accounts receivable   928
Inventory, net 20,951 21,072
Prepaid expenses and deposits 5,999  
Total current assets 48,706 39,621
Total assets 48,706 39,621
Current liabilities:    
Accounts payable and accrued liabilities 1,115,473 496,626
Due to shareholder 3,758 3,758
Due to related parties 126,183 371,051
Total current liabilities 1,245,414 871,435
Total liabilities 1,245,414 871,435
Commitment and contingencies
Stockholders' equity (deficit):    
Reserves 5,363,188 4,034,453
Subscription Receivable   (54,497)
Accumulated deficit (6,336,966) (4,628,139)
Accumulated other comprehensive loss (1,799) (2,764)
Total stockholders' equity (deficit) (Virax) (974,578) (650,682)
Non-controlling interests (222,130) (181,132)
Total stockholders' equity (deficit) (1,196,708) (831,814)
Total liabilities and stockholders' equity (deficit) 48,706 39,621
Ordinary Shares Class A    
Stockholders' equity (deficit):    
Ordinary Shares 304 223
Ordinary Shares Class B    
Stockholders' equity (deficit):    
Ordinary Shares $ 695 $ 42